147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Cellular fibronectin toolset

Expression vectors encoding human "cellular" fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) […]

Mouse anti-human fli-1 (friend leukemia virus integration 1) (clone

Targets : Human FLI-1 and EWS-FLI-1. Applications : Western-blot, Immunoprecipitation, intracellular immunofluorescence […]

Mouse anti-human/mouse/rat tspan5 (clones ts5-2 and ts5-3)

This mAb recognizes Tspan5, a member of the Tetraspanin superfamily. It recognizes the human, mouse and rat proteins which are 100% identical. First […]

Rat mesothelial cell line m2-0

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a male rat (Fischer F344) after 285 days of induction with crocidolite […]

Rat mesothelial cell line f2-4

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a female rat (Fischer F344) after 347 days of induction with crocidolite […]

Rat mesothelial cell line f2-3

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a female rat (Fischer F344) after 313 days of induction with crocidolite […]

Vhh directed against human darc

VHH (i.e. recombinant derivative of peculiar heavy chain only antibodies present in camelids) directed against Duffy antigen receptor for chemokines […]

Rat mesothelial cell line f3-1

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a female rat (Fischer F344) after 356 days of induction with crocidolite […]

Mouse anti-human melanoma associated antigen (clone pnl2)

- this new monoclonal antibody is directed against a new fixative resistant melanocyte/melanoma-associated antigen. - PNL2 labels more than 70% of […]

Profiling blood lymphocytes reactivity against cancer cells

In vitro trogocytosis of PKH67-stained cancer cells as a measure of their interactions with bulks of PBMC from patients. This profiling give the […]

More posts

You might also be interested in